Bioventus (BVS)
(Delayed Data from NSDQ)
$11.79 USD
-0.16 (-1.34%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $11.78 -0.01 (-0.08%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth F Momentum B VGM
Cash flow Statements
Fiscal Year End for Bioventus Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -195.63 | -213.39 | 9.59 | 14.72 | 0.00 |
Depreciation/Amortization & Depletion | 57.37 | 66.80 | 34.88 | 29.19 | 0.00 |
Net Change from Assets/Liabilities | -3.18 | -14.53 | -13.28 | 15.31 | 0.00 |
Net Cash from Discontinued Operations | 72.26 | 0.00 | 0.00 | -0.40 | 0.00 |
Other Operating Activities | 84.53 | 147.58 | -8.19 | 12.98 | 0.00 |
Net Cash From Operating Activities | 15.34 | -13.54 | 22.99 | 71.80 | 0.00 |
Property & Equipment | -7.36 | -10.04 | -7.37 | -4.09 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 34.68 | -104.84 | -262.87 | 0.00 | 0.00 |
Investments | 0.00 | -1.48 | -13.52 | -16.58 | 0.00 |
Other Investing Activities | -11.51 | -0.08 | 0.00 | 0.17 | 0.00 |
Net Cash from Investing Activities | 15.81 | -116.44 | -283.76 | -20.50 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.78 | 5.82 | 109.41 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | -23.26 | 59.62 | 166.20 | -10.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | -0.37 | -19.89 | 0.00 |
Other Financing Activities | -4.17 | -3.37 | -1.88 | 0.32 | 0.00 |
Net Cash from Financing Activities | -26.65 | 62.08 | 273.37 | -29.57 | 0.00 |
Effect of Exchange Rate Changes | 0.63 | 0.52 | -0.23 | 0.59 | 0.00 |
Net Change In Cash & Equivalents | 5.13 | -67.38 | 12.37 | 22.32 | 0.00 |
Cash at Beginning of Period | 31.84 | 99.21 | 86.84 | 64.52 | 0.00 |
Cash at End of Period | 36.96 | 31.84 | 99.21 | 86.84 | 0.00 |
Diluted Net EPS | -2.49 | -2.59 | -0.15 | 0.89 | 0.89 |
Fiscal Year End for Bioventus Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -38.09 | -5.98 | -195.63 | -187.97 | -179.18 |
Depreciation/Amortization & Depletion | 24.88 | 11.79 | 57.37 | 44.90 | 31.07 |
Net Change from Assets/Liabilities | -9.21 | -14.76 | -3.18 | -5.16 | 11.06 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 72.26 | 72.26 | 72.26 |
Other Operating Activities | 31.59 | 2.95 | 84.53 | 80.94 | 78.07 |
Net Cash From Operating Activities | 9.16 | -6.01 | 15.34 | 4.97 | 13.29 |
Property & Equipment | -0.37 | -0.29 | -7.36 | -6.99 | -4.96 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 34.68 | 34.90 | 34.90 |
Investments | -0.71 | -0.71 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -11.51 | -11.51 | -11.51 |
Net Cash from Investing Activities | -1.08 | -1.00 | 15.81 | 16.40 | 18.43 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.79 | 0.18 | 0.78 | 0.62 | 0.22 |
Issuance (Repayment) of Debt | -11.32 | -3.06 | -23.26 | -23.26 | -31.26 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -1.55 | -1.36 | -4.17 | -4.00 | -3.83 |
Net Cash from Financing Activities | -12.09 | -4.24 | -26.65 | -26.64 | -34.87 |
Effect of Exchange Rate Changes | -0.96 | -0.54 | 0.63 | 0.26 | 0.70 |
Net Change In Cash & Equivalents | -4.97 | -11.79 | 5.13 | -5.01 | -2.45 |
Cash at Beginning of Period | 36.96 | 36.96 | 31.84 | 31.84 | 31.84 |
Cash at End of Period | 31.99 | 25.17 | 36.96 | 26.83 | 29.39 |
Diluted Net EPS | -0.37 | -0.07 | -0.07 | -0.12 | -0.06 |